Xiaonan Cong

471 total citations
8 papers, 399 citations indexed

About

Xiaonan Cong is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Xiaonan Cong has authored 8 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Pharmacology. Recurrent topics in Xiaonan Cong's work include Ubiquitin and proteasome pathways (2 papers), Cancer, Lipids, and Metabolism (2 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). Xiaonan Cong is often cited by papers focused on Ubiquitin and proteasome pathways (2 papers), Cancer, Lipids, and Metabolism (2 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). Xiaonan Cong collaborates with scholars based in China and United States. Xiaonan Cong's co-authors include Lina Xu, Jinyong Peng, Lianhong Yin, Lingli Zheng, Xiaoming Zhao, Zhengfang Yi, Mingyao Liu, Shihong Peng, Yundong He and Meichun Hu and has published in prestigious journals such as Nature Communications, Cancer Letters and Oncotarget.

In The Last Decade

Xiaonan Cong

8 papers receiving 396 citations

Peers

Xiaonan Cong
Ahmed R. El‐Sheakh Egypt
Lirui Sun China
Qiuxia Lu China
Hangyu Wang China
Dake Cai China
Hyo-Yeon Kim South Korea
Elbert L. Myles United States
Yukinori Mera Japan
Shwu-Huey Liu United States
Ahmed R. El‐Sheakh Egypt
Xiaonan Cong
Citations per year, relative to Xiaonan Cong Xiaonan Cong (= 1×) peers Ahmed R. El‐Sheakh

Countries citing papers authored by Xiaonan Cong

Since Specialization
Citations

This map shows the geographic impact of Xiaonan Cong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaonan Cong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaonan Cong more than expected).

Fields of papers citing papers by Xiaonan Cong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaonan Cong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaonan Cong. The network helps show where Xiaonan Cong may publish in the future.

Co-authorship network of co-authors of Xiaonan Cong

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaonan Cong. A scholar is included among the top collaborators of Xiaonan Cong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaonan Cong. Xiaonan Cong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Huang, Chen, Ying Miao, Jing Wang, et al.. (2022). A novel small-molecule activator of unfolded protein response suppresses castration-resistant prostate cancer growth. Cancer Letters. 532. 215580–215580. 9 indexed citations
2.
Cong, Xiaonan, Yundong He, Haigang Wu, et al.. (2021). Regression of Castration-Resistant Prostate Cancer by a Novel Compound HG122. Frontiers in Oncology. 11. 650919–650919. 5 indexed citations
3.
Liu, Yongrui, Yuan He, Feifei Yang, et al.. (2017). A novel synthetic small molecule YF-452 inhibits tumor growth through antiangiogenesis by suppressing VEGF receptor 2 signaling. Science China Life Sciences. 60(2). 202–214. 10 indexed citations
4.
Lv, Fang, Xiaonan Cong, Wenshu Tang, et al.. (2017). Novel hemostatic agents based on gelatin-microbial transglutaminase mix. Science China Life Sciences. 60(4). 397–403. 14 indexed citations
5.
He, Yundong, Shihong Peng, Jinhua Wang, et al.. (2016). Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer. Nature Communications. 7(1). 13122–13122. 79 indexed citations
6.
Hu, Meichun, Shihong Peng, Yundong He, et al.. (2015). Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer. Oncotarget. 6(17). 15348–15361. 68 indexed citations
7.
Zhao, Xiaoming, Xiaonan Cong, Lingli Zheng, et al.. (2012). Dioscin, a natural steroid saponin, shows remarkable protective effect against acetaminophen-induced liver damage in vitro and in vivo. Toxicology Letters. 214(1). 69–80. 119 indexed citations
8.
Lu, Binan, Lina Xu, Xiaonan Cong, et al.. (2012). Mechanism investigation of dioscin against CCl 4 -induced acute liver damage in mice. Environmental Toxicology and Pharmacology. 34(2). 127–135. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ahmed R. El‐Sheakh Breakdown of academic impact, for papers by Lirui Sun Breakdown of academic impact, for papers by Qiuxia Lu Breakdown of academic impact, for papers by Hangyu Wang Breakdown of academic impact, for papers by Dake Cai Breakdown of academic impact, for papers by Hyo-Yeon Kim Breakdown of academic impact, for papers by Elbert L. Myles Breakdown of academic impact, for papers by Yukinori Mera Breakdown of academic impact, for papers by Shwu-Huey Liu
Rankless by CCL
2026